Thackray Helen M. - Insider Transactions

Filter

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BCRX	Helen Thackray	Officer	Nov 21 '25	Proposed Sale	7.11	43,275	307,685		Nov 21 04:29 PM
BCRX	Thackray Helen M.	Chief R&D Officer	Apr 03 '23	Sale	8.29	7,000	58,030	207,275	Apr 05 04:33 PM
BCRX	Thackray Helen M.	Chief R&D Officer	Dec 15 '22	Sale	10.89	3,125	34,031	133,275	Dec 19 04:58 PM
BCRX	Thackray Helen M.	Chief R&D Officer	Apr 01 '22	Sale	16.20	7,600	123,120	136,400	Apr 04 04:32 PM
CBIO	Thackray Helen M.	SVP Clinical Development, CMO	Dec 08 '17	Sale	15.01	2,000	30,020	148,615	Dec 12 04:14 PM

CBIO	Thackray Helen M.	SVP Clinical Development, CMO	Sep 18 '17	Sale	13.00	2,000	26,000	150,615	Sep 18 06:15 PM
CBIO	Thackray Helen M.	SVP Clinical Development, CMO	May 25 '17	Sale	15.57	2,000	31,140	152,615	May 30 04:07 PM
CBIO	Thackray Helen M.	SVP Clinical Development, CMO	May 19 '17	Sale	12.14	2,000	24,280	154,615	May 22 09:23 PM
CBIO	Thackray Helen M.	VP Clinical Development, CMO	Oct 03 '16	Sale	7.00	4,000	28,001	156,615	Oct 04 04:22 PM
CBIO	Thackray Helen M.	VP Clinical Development, CMO	Jul 20 '16	Sale	8.00	2,000	16,000	160,615	Jul 21 05:27 PM
CBIO	Thackray Helen M.	VP Clinical Development, CMO	Jul 01 '16	Sale	7.40	5,068	37,503	179,547	Jul 06 05:07 PM
CBIO	Thackray Helen M.	VP Clinical Development, CMO	Jul 05 '16	Sale	7.01	10,136	71,053	169,411	Jul 06 05:07 PM
CBIO	Thackray Helen M.	VP Clinical Development, CMO	Jul 06 '16	Sale	6.68	6,796	45,397	162,615	Jul 06 05:07 PM

Upgrade your FINVIZ experience